Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Aspirin might well be considered the top utility player in the medicine cabinet

This cheap over-the-counter drug can be used not only for fever, pain and arthritis, but to prevent heart attack, stroke or angina. It also may reduce the risk of colorectal cancer. Yet aspirin also has side effects worth considering, and its very accessibility may hamper its use.

8 Oct 2004

Canadian Rheumatology Association issues statement on Vioxx alternatives

The Canadian Rheumatology Association (CRA) has issued a statement to its 350 members and other interested parties, recommending alternative treatment considerations in the wake of the worldwide recall of Merck's rofecoxib, (Vioxx(R)) last week.

7 Oct 2004

Rheumatoid arthritis results from a combination of genetic susceptibility and environmental triggers

Rheumatoid arthritis (RA), like many chronic diseases of the immune system, likely results from a combination of genetic susceptibility and environmental triggers.

7 Oct 2004

Study underscores the need for improved prevention and treatment of torn knee ligaments among young female athletes

Of the more than 17 million players participating in organized soccer nationwide, 7 million are female. While offering an equal opportunity playing field for student athletes, soccer has one unfortunate gender bias: women are more susceptible to knee injury.

7 Oct 2004

18 percent of seniors with chronic conditions such as heart disease and depression skip medicines due to costs

A recent nationally representative survey of older adults finds that 18 percent of those with chronic conditions such as heart disease and depression skip some of their prescription medicines because of out-of-pocket cost pressures, and 14 percent do so at least every month.

6 Oct 2004

Immediate voluntary world-wide withdrawal of Vioxx (rofecoxib)

Pharmaceutical company, Merck Sharp & Dohme has announced an immediate voluntary world-wide withdrawal of the drug, Vioxx (rofecoxib), commonly used for patients with rheumatoid or osteoarthritis.

4 Oct 2004

First U.S. program to allow citizens to purchase lower cost, safe prescription drugs from Europe and Canada

Illinois Gov. Rod R. Blagojevich and Congressman Rahm Emanuel (D-Chicago) were joined in Chicago today by Wisconsin Governor Jim Doyle to launch the new I-SaveRx prescription drug importation program -- the first program in the nation to allow citizens to purchase lower cost, safe prescription drugs from Europe and Canada.

4 Oct 2004

MHRA advice following withdrawal of Vioxx (rofecoxib)

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued advice following the withdrawal of a widely-used pain-killer and anti-inflammatory drug Vioxx (rofecoxib).

4 Oct 2004

Data demonstrate that Celebrex does not increase the risk of heart attack or stroke in patients with arthritis and pain

Pfizer has said that three large long-term Celebrex (celecoxib capsules) studies involving more than 6,000 patients have not shown any significant safety issues and are expected to continue to completion.

4 Oct 2004

We could soon be curing our athlete’s foot with alfalfa

We could be soon be curing our athlete’s foot with a common type of cattle feed, according to research reported today at the British Pharmaceutical Conference.

29 Sep 2004

Study to test the effectiveness of anti-depressants in treating symptoms of Parkinson’s disease

While Parkinson’s disease typically brings to mind symptoms such as tremors and slow movement, researchers have found that nearly half of all Parkinson’s patients also suffer from depression. While it might seem natural that someone who has a disease such as Parkinson’s might become depressed, it’s not so simple, says neurologist Irene Richard, M.D., who leads the study.

27 Sep 2004

Study on the long-term health effects associated with silicone breast implants

It is estimated that between 1.5 million and 2 million women in this country have had breast implants since they first appeared on the market in 1962.

23 Sep 2004

FDA proposed new egg safety regulations to reduce Salmonella Enteritidis cases

When implemented, the production changes defined by the regulation will significantly reduce the number of illness caused by eggs contaminated with Salmonella Enteritidis.

20 Sep 2004

So far only 4,000 of 50,000 slots have been filled in new demonstration prescription drug assistance program

The Chairman of the U.S. Senate Special Committee on Aging is encouraging those on Medicare who have cancer and other serious diseases to consider signing up for a new demonstration prescription drug assistance program.

18 Sep 2004

Cancer drug effective at treating lupus

A drug now used to treat a type of cancer appears to be very effective at treating lupus, with just one injection easing symptoms in several patients for a year or more.

16 Sep 2004

Cancer drug may reduce kidney disease in lupus

A drug that is already being tested as an anticancer agent, especially in lymphoma, may also reduce the kidney disease that is a result of systemic lupus, according to a researcher at Wake Forest University Baptist Medical Center.

10 Sep 2004

Study looks at the patient-practitioner relationship in complementary and alternative therapies

Why do patients opt for complementary and alternative therapies when they are ill? Is the relationship and communication between a patient and a practitioner as important in the treatment as the complementary treatments prescribed?

6 Sep 2004

Researchers unravel genetic makeup of ticks to tackle disease

Ticks as small as a freckle can transmit a number of illnesses for which there is no vaccine and, in some cases, no cure. These creatures even could become bioterrorism weapons.

4 Sep 2004

Are Latin America and the Caribbean ready to meet the health challenges of the coming senior boom?

Advances in medicine and public health have dramatically increased life expectancy in Latin America and the Caribbean.But is the region ready to meet the challenges of the coming "senior boom"?

31 Aug 2004

Common enzyme acts as a natural brake to prevent potentially deadly runaway inflammation

An enzyme found in nearly all animal and human cells acts as a natural brake to prevent potentially deadly runaway inflammation, UCSF scientists have discovered.

30 Aug 2004

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Aspirin might well be considered the top utility player in the medicine cabinet

Canadian Rheumatology Association issues statement on Vioxx alternatives

Rheumatoid arthritis results from a combination of genetic susceptibility and environmental triggers

Study underscores the need for improved prevention and treatment of torn knee ligaments among young female athletes

18 percent of seniors with chronic conditions such as heart disease and depression skip medicines due to costs

Immediate voluntary world-wide withdrawal of Vioxx (rofecoxib)

First U.S. program to allow citizens to purchase lower cost, safe prescription drugs from Europe and Canada

MHRA advice following withdrawal of Vioxx (rofecoxib)

Data demonstrate that Celebrex does not increase the risk of heart attack or stroke in patients with arthritis and pain

We could soon be curing our athlete’s foot with alfalfa

Study to test the effectiveness of anti-depressants in treating symptoms of Parkinson’s disease

Study on the long-term health effects associated with silicone breast implants

FDA proposed new egg safety regulations to reduce Salmonella Enteritidis cases

So far only 4,000 of 50,000 slots have been filled in new demonstration prescription drug assistance program

Cancer drug effective at treating lupus

Cancer drug may reduce kidney disease in lupus

Study looks at the patient-practitioner relationship in complementary and alternative therapies

Researchers unravel genetic makeup of ticks to tackle disease

Are Latin America and the Caribbean ready to meet the health challenges of the coming senior boom?

Common enzyme acts as a natural brake to prevent potentially deadly runaway inflammation

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in